Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab

Clinical trial NCT06003998 · UNKNOWN

Trial details

NCT number: NCT06003998
Sponsor: Catharina Ziekenhuis Eindhoven
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Peritoneal Metastases

Start date: 2022-12-27
Primary completion: 2025-01-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.